Wells Fargo
SVNT

Wells Fargo’s SAVIENT PHARMACEUTICALS INC SVNT Stock Holding History

Wells Fargo’s Portfolio SVNT Stock Details SVNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-1,800
Closed -$1K – 6268
2013
Q3 		$1K Buy
1,800
+200
+13% +$128 ﹤0.01% 5601
2013
Q2 		$1K Buy
+1,600
New +$1.11K ﹤0.01% 5523

Other funds holding SVNT

Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
FHC
First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return
PSC
Prentiss Smith & Co Brattleboro, Vermont $172M AUM 21.18% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Wells Fargo's SVNT Position: Q4 2013 in Review

Wells Fargo sold out of SAVIENT PHARMACEUTICALS INC (SVNT) in Q4 2013, closing a stake of 1,800 shares — an estimated $1K sold.

Wells Fargo first reported a position in SVNT in Q2 2013 and held it in 2 quarters. The position peaked at $1K in Q3 2013. 7 funds tracked by Wall St. Rank hold SVNT as of Q4 2013.

  • Wells Fargo reported no remaining SAVIENT PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Wells Fargo sold 1,800 SAVIENT PHARMACEUTICALS INC shares in Q4 2013, an estimated $1K.
  • Wells Fargo first reported a position in SAVIENT PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Wells Fargo's SAVIENT PHARMACEUTICALS INC position peaked at $1K in Q3 2013.
  • 7 funds tracked by Wall St. Rank held SAVIENT PHARMACEUTICALS INC as of Q4 2013.

Based on Wells Fargo's 13F filing for Q4 2013, filed 6 Feb 2014.